Duane Pinto, MD
Interventional Cardiology · Boston, MANPI 1275521130
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (50.9%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Abbott at 45.8% of the total. Reporting peaked in 2019 at $107,310 and has fallen 54.4% since, to $48,956 in 2025. Among interventional cardiology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 488 payments — averaging $1005.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$225K
- Abiomed$109K
- Medtronic$53K
- Boston Scientific$34K
- Terumo Medical Corporation$18K
- Gilead$14K
- plus $38K from 17 others
Across 100 payments — averaging $37,252 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- CSL Behring$2.9M
- Boston Scientific$697K
- Medtronic$66K
- Neovasc Medical Inc$18K
- Novo Nordisk AS$555
What the payments were for
- Consulting fees$249,75251%
- Speaking & faculty fees$151,21331%
- Travel & lodging$68,81814%
- Food & beverage$20,8564%
- Gifts$100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 228 | $224,887 |
| Abiomed | 80 | $108,886 |
| Medtronic(2 entities) | 75 | $52,783 |
| Boston Scientific | 31 | $33,687 |
| Terumo Medical Corporation | 28 | $17,843 |
| Gilead | 7 | $14,205 |
| Magenta Medical Inc | 6 | $9,249 |
| CSL Behring | 4 | $7,800 |
| Vascular Solutions, Inc. | 1 | $6,000 |
| Biotronik Inc. | 10 | $5,756 |
| Haemonetics Corporation | 1 | $3,000 |
| Opsens Inc. | 1 | $2,000 |
| Shockwave Medical, Inc | 1 | $1,500 |
| Inari Medical, Inc. | 1 | $1,000 |
| Cordis US CORP. | 1 | $667 |
| Siemens Medical Solutions USA, Inc. | 4 | $376 |
| Cathworks, Inc. | 1 | $261 |
| Neovasc Medical Inc | 2 | $202 |
| Arrow International, Inc. | 2 | $186 |
| Philips North America LLC | 1 | $147 |
| Saranas, Inc. | 1 | $108 |
| Edwards Lifesciences | 1 | $82 |
| Corindus Inc. | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OPTIS$124,652
- Impella$108,274
- Xience V coronary stent system$41,006
- DRAGONFLY OPSTAR$32,107
- Resolute$23,004
- GENERAL - THERAPIES$13,747
- ADVISOR$12,122
- LOTUS EDGE$10,816
- GENERAL - STRUCTURAL HEART$7,139
- MANTA$6,153
- GlideWire$5,152
- METACROSS OTW$5,152
- COREVALVE EVOLUT R$3,793
- RESOLUTE ONYX$3,375
- Azur CX Detachable$3,336
- TEG6s HEMOSTASIS SYSTEM$3,000
- GLIDESHEATH SLENDER$2,941
- Perclose ProGlide suture mediated closure system$2,250
- OptoWire$2,000
- OptoMonitor$2,000
How this compares
$490,648 in reported general payments places this provider in the 95th percentile of 128 interventional cardiology providers in Massachusetts.
See all interventional cardiology providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Boston
- Eric SecemskyBoston$1.2M
- Darshan DoshiBoston$730K
- Charles GibsonBoston$661K
- Robert YehBoston$412K
- Suzanne BaronBoston$274K
- Farouc JafferBoston$213K
- Joseph GarasicBoston$152K
- Pinak ShahBoston$147K
- Douglas DrachmanBoston$132K
- Hector Tamez AguilarBoston$123K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.